AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+10.19%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$101M
AUM Growth
+$101M
(+3.9%)
Cap. Flow
-$4.04M
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
22.09%
Holding
226
New
42
Increased
62
Reduced
35
Closed
61
Top Buys
| 1 |
Ultragenyx Pharmaceutical
RARE
|
$1.25M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
$1.16M |
| 3 |
ADC Therapeutics
ADCT
|
$1.14M |
| 4 |
Novavax
NVAX
|
$1.08M |
| 5 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$1.07M |
Top Sells
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$12.8M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
$2.1M |
| 3 |
Invesco S&P 500 Pure Value ETF
RPV
|
$2.08M |
| 4 |
Sanofi
SNY
|
$1.72M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
$1.59M |
Sector Composition
| 1 | Healthcare | 56.8% |
| 2 | Real Estate | 15.08% |
| 3 | Financials | 8.32% |
| 4 | Energy | 6.75% |
| 5 | Industrials | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Collegium Pharmaceutical
COLL
$1.24B
| $1.15M | 1.13% |
49,500
-19,000
| -28% | -$441K |
|
|
27
ADC Therapeutics
ADCT
$346M
| $1.14M | 1.13% |
+297,500
| New | +$1.14M |
|
|
ONIT
28
Onity Group Inc.
ONIT
$334M
| $1.09M | 1.08% |
35,618
| – | – |
|
|
29
Novavax
NVAX
$1.22B
| $1.08M | 1.07% |
+105,000
| New | +$1.08M |
|
30
BioXcel Therapeutics
BTAI
$58.7M
| $1.07M | 1.06% |
50,000
| – | – |
|
|
DX
31
Dynex Capital
DX
$1.61B
| $1.06M | 1.05% |
+83,590
| New | +$1.06M |
|
32
Ametek
AME
$42.5B
| $1.05M | 1.04% |
7,500
| – | – |
|
|
SLGC
33
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $1.04M | 1.03% |
415,000
+187,500
| +82% | +$471K |
|
34
Viridian Therapeutics
VRDN
$1.53B
| $1.04M | 1.02% |
35,500
| – | – |
|
35
Stereotaxis
STXS
$247M
| $1.04M | 1.02% |
500,000
| – | – |
|
36
Innoviva
INVA
$1.32B
| $994K | 0.98% |
75,000
+7,000
| +10% | +$92.8K |
|
|
37
Sanofi
SNY
$120B
| $969K | 0.96% |
20,000
-35,500
| -64% | -$1.72M |
|
38
AGNC Investment
AGNC
$10.1B
| $960K | 0.95% |
92,746
+54,150
| +140% | +$560K |
|
|
RWT
39
Redwood Trust
RWT
$771M
| $888K | 0.88% |
131,398
| – | – |
|
40
Mobileye
MBLY
$11.1B
| $877K | 0.87% |
+25,000
| New | +$877K |
|
|
PETQ
41
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $876K | 0.87% |
95,000
-84,000
| -47% | -$774K |
|
42
Lantheus
LNTH
$3.73B
| $866K | 0.86% |
+17,000
| New | +$866K |
|
|
CINC
43
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $860K | 0.85% |
+70,000
| New | +$860K |
|
|
TARO
44
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $799K | 0.79% |
27,500
+3,000
| +12% | +$87.1K |
|
45
Acadia Pharmaceuticals
ACAD
$4.39B
| $796K | 0.79% |
+50,000
| New | +$796K |
|
46
Annaly Capital Management
NLY
$13.4B
| $791K | 0.78% |
37,500
| – | – |
|
47
DocGo
DCGO
$152M
| $778K | 0.77% |
+110,000
| New | +$778K |
|
48
Omnicell
OMCL
$1.47B
| $756K | 0.75% |
15,000
+5,000
| +50% | +$252K |
|
49
Globus Medical
GMED
$8.13B
| $743K | 0.73% |
10,000
+9,000
| +900% | +$668K |
|
50
Pacira BioSciences
PCRX
$1.21B
| $734K | 0.72% |
+19,000
| New | +$734K |
|